FY21 facilities task order e (NCI-osfm-21-0102)
Ended Awarded Last action
- Contract number
- 75N91021F00008
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,778,014
Award facts
- Contract value 100% obligated
- $1,778,014.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $550,335 | |
| Original award | $1,227,679 |
About this award
Leidos Biomedical Research Inc. was awarded a $1.778 million delivery order against an unspecified federal supply schedule by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The cost-plus-fixed-fee task order, issued on August 11, 2021 with a performance period through August 31, 2023, is for facilities support services to be performed at Fort Detrick, Maryland in furtherance of NCI's biomedical research mission. As the prime contractor, Leidos will draw on its parent company Leidos Holdings' experience supporting government scientific agencies while coordinating any necessary subcontractor resources. No set-aside designation or additional vehicle details were provided in the award information.
Quick answers
Who was awarded contract 75N91021F00008?
75N91021F00008 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 11, 2021.
How much is contract 75N91021F00008 worth?
The government has obligated $1,778,014 on 75N91021F00008.
Is contract 75N91021F00008 an order under another contract?
Yes. 75N91021F00008 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00008 competed?
The extent of competition for 75N91021F00008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award